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We have previously described the first homozygous cases of Hb Knossos in an Algerian family. The Hb As was completely 
absent, ascertaining the presence of a S”-thalassemia determinant in cb of the /P -s gene. Here, we investigate the af- 
fected &globin gene. The complete DNA sequence of the gene and its 5’ and 3’ flanking regions was determined. Only 
two nucleotide changes were recorded: a C + T substitution at - 199 and an AT insertion at -448 upstream from the 
cap site. To examine the involvement of these changes in gene function, the &gene was subcloned in an expression vector 
and introduced into COS cells. Analysis of RNA derived from these cells, using an S, protection assay and dot-blot hybri- 
dization, revealed qualitatively and quantitatively normal transcription. The loss of &globin gene activity in vivo may 
be due to the alteration of a tissue-specific control. 
Gene, &globin; DNA sequence polymorphism; Thalassemia; Transient expression 
1. INTRODUCTION 
The bglobin chain is the &like subunit of the 
minor adult hemoglobin (Hb), Hb AZ, which is 
synthesized at about 2.5% in normals [l]. The 
underproduction of d-globin chains results, at least 
in part, from the imperfect constitutive S-promoter 
structure [2]. bThalassemia is rather a rare condi- 
tion which has been identified mainly in Mediterra- 
neans [3-51 and Japanese [6,7] individuals. Like 
P-chain synthesis in fl-thalassemia, both partial 
and total suppression of S-globin chain synthesis 
occur in S-thalassemia, giving rise to 6+ and 6” 
forms, respectively. 
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Increased Hb AZ is a major criterion for 
diagnosis of the &thalassemia trait. Nevertheless, 
distinct forms of non-deletion Bthalassemia are 
associated with normal Hb AZ, suggesting the co- 
inheritance of separate fl- and S-thalassemia deter- 
minants [4,8-lo]. Hb Knossos (B 27 Ala - Ser) 
is a structural variant with a mild ,&-thalassemia 
phenotype and an almost constant decrease in Hb 
A2 percentage in heterozygotes [8]. The presence of 
a Z’-thalassemia (P-thal) determinant in cis of the 
P Knossos gene has been demonstrated in a 
~/&+.epore ] double heterozygote [l l] and, 
more recently, in homozygous Hb Knossos [12]. 
Here, we have analysed the S-globin gene isolated 
from a previously reported patient with 
homozygous Hb Knossos [12]. A single base 
substitution at - 199 and an AT insertion at - 448 
have been identified in 5 ’ of an otherwise normal 
a-gene. Assays of transient expression in COS cells 
showed the affected gene to be quantitatively and 
qualitatively normally expressed. 
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Fig.1. DNA sequence of the b-thal gene (a”). Nucleotide 
changes are depicted at the bottom, in comparison with a 
normal bglobin gene, considered as the reference (JRef) [16]. 
2. MATERIALS AND METHODS 
2.1. Gene cloning and DNA sequencing 
DNA was obtained from peripheral blood leucocytes and an 
enriched library was constructed in bacteriophage hL47 as 
described [13]. The bglobin gene was cloned as a 7-8 kb EglII 
fragment by substitution of the central BumHI fragment of the 
phage. A 2.3 kb PstI fragment containing the entire J-gene was 
subcloned in Ml3 mp18 and Ml3 mp19 vectors. Its complete 
nucleotide sequence was determined by the dideoxy method of 
Sanger et al. [14], using several Ml3 templates containing AM, 
NueIII, RsuI or Sau3A restriction fragments derived from the 
2.3 kb PstI insert. 
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Fig.2. Dot-blot analysis of the &mRNA level following transient assay in COS cells. (Top) Autoradiograph of duplicated filters after 
hybridization with (Y- and &probes. tRNA is a negative control. SN and 6” refer to normal and thalassemic genes, respectively. (6’+(r) 
RNA from 6 and CY co-transfected cells. 1 and 2 indicate RNAs extracted from two different culture dishes. (O+cy) RNA from cells 
transfected only by n-recombinant plasmid. (Bottom) Plots of radioactivity count vs increasing quantities of RNA applied to 
nitrocellulose filters; radioactive spots were excised from filters and determined by liquid scintillation counting. 
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2.2. Gene expression in COS cells 
A 2.3 kb PstI fragment containing either the b-thal or nor- 
mal J-gene was subcloned in pEMBL 8 SV expression vector 
containing the SV40 enhancer element [IS]. The recombinant 
plasmids were co-transfected in COS cells with an cy-globin gene 
recombinant plasmid as an internal standard [15]. 
Dot-blot assay of COS cell RNA was carried out as in [13]. 
Duplicate nitrocellulose filters were hybridized with anti- 
mRNA probes encompassing either 6- or cy-globin exon 1. These 
probes were prepared using Tr RNA polymerase and Bluscribe 
recombinant DNA templates. 
Analysis of COS cell RNA was performed by Si nuclease 
mapping according to [13,15]. Two uniformly “P-labeled 6- 
globin gene probes were prepared from single-strand Ml3 
clones containing a normal b-globin 2.3 kb PstI fragment: (i) a 
950 bp BunrHI/HindIII fragment encompassing exon 1 and the 
5 ’ -end of exon 2; and (ii) a 550 bp HpuI fragment containing 
exon 3. 
3. RESULTS 
3.1. Sequence analysis 
The nucleotide sequence of the &thal gene was 
examined from 458 bp 5 ’ to site to 207 bp 
3 ’ to the polyadenylation signal. Comparison with 
a reference sequence [16] led to the detection of 
two variations: C + T substitution at - 199 and 
AT insertion at -448 upstream from the cap site 
(fig.1). No abnormal sequence was found to ex- 
plain the dysfunction of this gene in vivo. 
3.2. Transient expression in heterologous ceils 
The S-thal gene and its flanking regions in- 
cluding the two mentioned variations were in- 
troduced together as recombinant plasmid in 
cultured COS cells. Transient expression of the af- 
fected gene and a normal &gene was examined in 
the presence of an equal amount of a co- 
transfected cy-globin gene as an internal control. 
Dot-blot assay was performed on transfected 
COS cell RNA to evaluate quantitative expression 
of the S-thal gene. RNA analysis with both (Y- and 
S-globin riboprobes would allow monitoring of 
variability due to differences in transfection effi- 
ciency or RNA recovery. As shown in fig.2, there 
was no difference in the quantity of &globin 
mRNA transcribed from each b-globin. 
Alternatively, RNAs derived from COS cells 
were analysed with respect to the functional in- 
tegrity of the b-thal gene by Sr nuclease mapping, 
using two 6 single-strand DNA probes: the first 
probe is protected by S-globin mRNA to produce 
a 143-nucleotide fragment encompassing the 
234- 
213- -0X 2 
loa- 267- 
134- -e23 ) 
234- 
213- 
-+A- --t&m- 
-__-, - -___ 
-- 
w 201 Rotecw 6a@leMs zi 
Fig.3. Sr mapping of Gglobin gene transcripts derived from 
transfected COS cells. Uniformly labeled probes and protected 
fragments (with their expected lengths) are depicted at the 
bottom of schematic diagrams of the &globin gene. The broken 
line signifies that the end of the probe is within the Ml3 
polylinker. The low intensity of exon 1 protected bands (b) 
results from the low specific activity of the probe in this region, 
due to the primer extension reaction. 6” and SN, see legend to 
fig.2. M, “P-labeled HaeIII pBR322 restriction fragments used 
as size markers. All sizes expressed in base pairs. 
5 ‘-untranslated region and all of exon 1, and a 
205nucleotide fragment containing exon 2 to the 
BarnHI site. The second probe is protected by nor- 
mally spliced B-globin mRNA to produce a 
258-nucleotide fragment encompassing all of exon 
3. As demonstrated by the presence of the expected 
bands and their equal intensities, the bthal gene in- 
itiates transcription normally and produces a 
transcript from which the two introns are spliced 
correctly. 
4. DISCUSSION 
In &fl-thalassemia nd some HPFH conditions, 
the &globin gene is usually deleted, and therefore 
completely unexpressed. In contrast, no large dele- 
tion affecting this gene was observed in b-thal con- 
ditions [5,7,17-191. Only two mutations are 
known to be responsible for the &thal phenotype 
[51. 
In the present study, we tried to define the 
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molecular defect of the So-thal gene present in cis 
of the ~ gene. The restriction haplotype sug- 
gested the absence of an extended deletion around 
the &gene [12]. The DNA sequence was normal 
and the gene was expressed normally when in- 
troduced into COS cells. 
Both the two nucleotide changes observed at 
- 199 and - 448 upstream from the cap site have 
been encountered in a Japanese individual in 
whom &globin gene was expressed normally in 
vivo. They have also been found to be associated 
with a T + C substitution at - 77 of a 6”-thal gene 
[7]. There is no evidence that the -77 base 
substitution is involved in the 60-thal phenotype. 
Nevertheless, the present 6”-thal gene is flanked by 
a T at - 77 in the 5 ’ -side, and a ,&KnossOs mutation 
in the 3 ‘-side, and is associated with a different fl- 
globin gene cluster haplotype [12]. It should 
therefore differ from the b”-thal gene described in 
Japan. 
The finding that an intact &globin gene is inac- 
tive in vivo on a chromosome bearing no large 
deletion at its proximity rules out a mechanism 
identical to that involved in some y&thalassemia 
(review [l]); which inactivates a structurally nor- 
mal @globin gene. Nevertheless, in the Japanese 
and the Z’-thal described here, the molecular lesion 
appears to be associated with erythroid-specific 
control of the S-gene, since either of the two genes 
was expressed normally in heterologous cells. 
Recently, the DNA sequence at - 200, and with 
lower efficiency that at - 120, upstream from the 
human fl-globin gene, have been shown to bind a 
specific nuclear erythroid factor, NF-El [20]. 
These sites contain a consensus sequence, T/A 
ATC A/T Py (with a mismatch at - 119) also 
found in the 3 
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